baber/WOPTO huggingface dataset:
Patent FI-953377-A0 (FI)
Inventor: LARSON GARY B
IPC: H05K3/06
Filed: 1995-07-10
Abstract: Composition and methods for providing a phosphate conversion coating on a metal surface, particularly a copper surface, characterized in that the phosphating composition includes at least one composition-soluble compound containing vanadium, niobium, tungsten or tantalum. The phosphate conversion coatings so produced are thicker, more durable and more uniform than those produced by known phosphating compositions. The compositions and processes are especially useful for providing a passivating/uniformizing coating layer on copper surfaces to which organic resin is thereafter deposited to serve as a resist in printed circuit fabrication sequences, particularly when the organic resin is an electrophoretically deposited organic resin. Also described is the microetching of copper surfaces with a phosphoric acid/peroxide microetchant preparatory to deposit thereon (or after a further provision of a phosphate conversion coating) of a photoresist which is then imagewise exposed and developed to provide a patterned resist.
Patent FI-953749-A0 (FI)
Inventor: KATISKO KEIJO
IPC: H04B1/40
Filed: 1995-08-07
Abstract: PCT No. PCT/FI96/00431 Sec. 371 Date Apr. 4, 1997 Sec. 102(e) Date Apr. 4, 1997 PCT Filed Aug. 6, 1996 PCT Pub. No. WO97/06607 PCT Pub. Date Feb. 20, 1997Amplitude and phase errors between branches I and Q of a transceiver utilizing phase quadrature modulation are corrected by preventing propagation of a nominal-frequency signal from a digital part through a loop part and a reception branch to an RSSI indicator by changing the frequency response of a component on the path of the signal. The same indicator that normally measures the payload signal, here measures only undesired signal components. After this, such amplitude and/or phase correction signals are determined with which the measuring result obtained from the indicator reaches the minimum. The resultant correction signals are stored in the memory, and the frequency response of the system is then restored to normal.
Patent FI-955139-A0 (FI)
Inventor: JIANG HAO
IPC: H04L69/40
Filed: 1995-10-27
Abstract: The invention relates to a tele- and data communication system, including circuits containing transfer paths for data flows, and having functionality for error isolation of parts of the system. At least partially, where possible, parts of the circuits of the system are error isolated by logical partition into function blocks of two types. More particularly there is a first type, in which a complete corresponding function block need not necessarily become eliminated by an occurring error, and a second type in which the contrary is true. The transfer paths of a function block of the first type are isolated from each other for enabling shutting down such an erronous transfer path from traffic by software control.
Patent FI-960053-A0 (FI)
Inventor: FRYKHULT SIRI VIKTORIA
IPC: B01D33/11
Filed: 1996-01-05
Abstract: PCT No. PCT/SE94/00660 Sec. 371 Date Dec. 12, 1995 Sec. 102(e) Date Dec. 12, 1995 PCT Filed Jul. 4, 1994 PCT Pub. No. WO95/01825 PCT Pub. Date Jan. 19, 1995An apparatus for filtering liquids, such as fiber suspensions or polluted water, includes a hollow rotating filter body adapted to receive the liquid to be filtered within the body. A plurality of guide members are attached to the filter body and distributed around the latter to receive cloudy filtrate penetrating the filter body at the descending side. A basin is arranged at the descending side of the filter body to collect cloudy filtrate poured from the guide members. As a result, the cloudy filtrate is prevented from mixing with the clear filtrate.
Patent FI-963198-A0 (FI)
Inventor: ROMOCKI JULIAN
IPC: C09K8/72
Filed: 1996-08-15
Abstract: New compositions are disclosed that are useful for the prevention of sludge or emulsions during the drilling or workover of producing oil wells. These compositions are comprised of a N,N-dialkyl amide of a fatty acid, a hydrocarbon solvent for petroleum and a mutual oil/water solvent. Also taught and claimed is a method of preventing such sludge or emulsion formation or of breaking the same after it is formed.
Patent FI-970457-A0 (FI)
Inventor: BERNIER ROBERT JOSEPH NOEL
IPC: C08F36/04
Filed: 1997-02-03
Abstract: Polymers are produced in a stirred bed or gas fluidised bed polymerisation zone of growing polymer particles by (1) introducing a stream of monomer(s), and opt. inert gas(s) or liq(s)., into the polymerisation zone; (2) continuously or intermittently introducing a catalyst; (3) continuously or intermittently withdrawing polymer; and (4) continuously withdrawing unreacted gases, compressing and cooling the gases while maintaining the temp. in the polymerisation zone below the dew pt. of at least one monomer; with the proviso that if there is only one monomer present in the feed stream, an inert gas is also present.
Patent FI-972534-A0 (FI)
Inventor: VAEAENAENEN JANNE
IPC: H02P21/12
Filed: 1997-06-13
Abstract: The invention relates to a method of ensuring the stability of a synchronous machine in controlling the synchronous machine on the basis of direct control of flux and torque, in which the torque generated by the synchronous machine is increased/decreased by increasing/decreasing the instantaneous angular velocity of the stator flux. In accordance with the invention, the method comprises the steps of determining the direction of the stator flux vector ( psi s) in rotor coordinates (dq), and forcing the stator flux vector ( psi s) to remain in quadrants I and IV (Q1, Q4) of the rotor coordinates by rotating the stator flux in the rotor coordinates to a necessary degree. <IMAGE>
Patent IL-61601-A0 (IL)
Title: Process for preparing 11-keto steroids
IPC: C07J1/00
Filed: 1980-12-01
Abstract: A process for preparing an 11-keto steroid consists essentially of heating the corresponding 9 alpha -halo-11 beta -hydroxy steroid, to 180 DEG -350 DEG  C. in an inert, aprotic, high-boiling solvent.
Patent IL-70747-A0 (IL)
Title: Benzoylurea compounds,their preparation and pesticidal and pharmaceutical compositions containing them
IPC: A61K31/17
Filed: 1984-01-23
Abstract: The invention relates to new benzoylurea compounds of the general formulawhereinR<sub>1</sub> is a halogen atom,R<sub>2</sub> is a hydrogen atom or a halogen atom,R<sub>3</sub> is a hydrogen atom or represents 1 or 2 substituents which are selected from the group consisting of chlorine, methyl and trifluormethyl,R<sub>4</sub> is a hydrogen atom or represents 1-3 substituents which are selected from the group consisting of halogen, and alkyl, alkoxy, haloalkyl and haloalkoxy, having 1-4 carbon atoms,X is N or CH,n is 0 or 1, andR<sub>5</sub> is a hydrogen atom, an alkyl group having 1-6 carbon atoms, an alkenyl group having 2-6 carbon atoms, or a cycloalkyl group having 3-6 carbon atoms, with the proviso, that, if n is 0 and R<sub>s</sub> is a hydrogen atom, R<sub>3</sub> is a hydrogen atom.The compounds have an -insecticidal and acaricidal activity. After having been processed to compositions, the compounds may be used for the control of insects and/or mites in a dosage of 1 to 5000 grams of active substance per hectare. In addition the compounds have an antitumor activity and may be used in pharmaceutical compositions.
Patent IL-72393-A0 (IL)
Title: Protected pentapeptides useful in the synthesis of pentapeptides
IPC: C07F9/24
Filed: 1984-07-12
Abstract: Solution phase methods and compositions for preparing H-ARG-X-Z-Y-TYR-R wherein X is LYS and Y is VAL or X and Y are both SAR, Z is ASP or GLU, and R is NH<sub>2</sub> or OH.
Patent IL-75772-A0 (IL)
Title: 9-or 11-substituted apovincaminic acid derivatives and their preparation
IPC: C07B61/00
Filed: 1985-07-11
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, NL, SE Racemic or optically active 9- and/or 11-substituted apovincamic acid derivatives having the general formula  see diagramm : EP0173824,P11,F1  wherein R is a nitro or amino group in position 9 or 11, and the salts thereof. 1. Claims for the Contracting State : AT A process of producing racemic or optically active 9- and/or 11-substituted apovincamic acid derivatives having the general formula  see diagramm : EP0173824,P11,F3  wherein R is a nitro or amino group in position 9 or 11, and salts thereof, characterized in that apovincamic acid having the formula  see diagramm : EP0173824,P11,F4  is nitrated and the resulting 9- and/or 11-(nitro)- apovincamic acid(s) is or are optionally reduced, optionally after it has or they have been isolated from the reaction mixture and, optionally the resulting 9- and/or 11-substituted apovincamic acid derivatives having the general formula I are transformed to acid addition salts or quaternary salts and/or metal salts and/or ammonium salts and/or the resulting salts of 9- and/or 11-substituted apovincamid acid derivatives having the general formula I are transformed to the free 9- and/or 11-substituted apovincamic acid derivatives having the general formula I or to other acid addition salts and/or quaternary salts and/or metal salts and/or ammonium salts and/or the resulting racemic 9- and/or 11-substituted apovincamic acid derivatives having the general formula I and/or the acid addition salts and/or quaternary and/or metal salts and/or ammonium salts are dissociated to its or their optical antipodes and/or the corresponding optically active compounds are racemized to form stereo-isomers.
Patent IL-84679-A0 (IL)
Title: Device for closing a wound and a method of using the device
IPC: A61B17/03
Filed: 1987-12-02
Abstract: A gaping surgical incision can be closed by drawing the edges of the incision toward one another by the application of traction to the wound. Adhesive strips which project beyond support tapes of a conventional garment-type slide fastener stringer are then applied to the skin along the incision and the slider is closed to provide a healing closure for the wound. Spacer strips between the skin and the support tapes are spaced outwardly from the respective coupling elements to define a free space and prevent the wound from contacting the coupling elements or the support tapes.
Patent IL-90560-A0 (IL)
Title: Phenothiazine derivatives,method for their preparation and pharmaceutical compositions containing them
IPC: C07D279/28
Filed: 1989-06-07
Abstract: New phenothiazine derivatives of general formula (I) in which Y is hydrogen or halogen, R1 and R2, which are identical or different, denote alkyl, cycloalkylalkyl, hydroxyalkyl or acetyloxyalkyl radicals or together with nitrogen atom to which they are attached form a saturated or partially unsaturated heterocyclic ring containing 4 to 7 chain links and optionally substituted and either X is oxygen, sulphur or N-R4, R is cycloalkyl, phenyl or -CH2R3, R3 is H, C1-5 alkyl, alkenyl or C2-4 alkynyl, C3-6 cycloalkyl, phenyl, substituted phenyl or heterocyclyl, R4 is H or -CN, with the exception that X denotes oxygen if simultaneously R3 is H or alkyl, R1 and R2 are alkyl or NR1R2 forms an unsubstituted heterocyclic ring and Y is H; or X is N-R4 and R4 forms with R and the neighbouring atoms an imidazolinyl or optionally substituted imidazolyl or hexahydrobenzimidazolyl radical, in their isomeric forms and mixtures thereof, their addition salts with acids, their preparation and the pharmaceutical compositions containing them. 
<??>These products are particularly advantageous as analgesics and diuretics. 
<IMAGE>
Patent IL-96309-A0 (IL)
Title: Polypeptides,dna sequences coding therefor and their preparation
IPC: C12R1/19
Filed: 1990-11-12
Abstract: The present invention concerns a DNA sequence coding for a polypeptide with enantioselective amidase activity.
Patent IL-104019-A0 (IL)
Title: Mixtures of 1,1,1-trifluoroethane and perfluoropropane and their applications as refrigerants,as aerosol propellants or as plastic foam-expanding agents
IPC: C09K3/30
Filed: 1992-12-08
Abstract: To replace chlorofluorocarbons as refrigerating fluids, the invention proposes to employ mixtures containing, on a mass basis, approximately 40 to 70 % of 1,1,1-trifluoroethane and 30 to 60 % of perfluoropropane. The mixtures according to the invention can also be employed as aerosol propellants or as blowing agents for plastic foams.
Patent IL-114112-A0 (IL)
Title: Process for obtaining permselective properties of membranes
IPC: B05D7/24
Filed: 1995-06-12
Abstract: The instant invention is directed toward a process for enhancing the permselective properties, selectively sealing defects and pinholes, controllably altering the pore size and stabilizing the permselective properties of articles having apperatures therein comprising the steps of: simultaneously contacting an article having a first and second surface, said first and second surfaces being capable of passing ozone and silicon compounds therethrough and said first and second surfaces being oriented such that said silicon compounds and ozone can react across said first and second surfaces, with ozone on said first surface and a silicon compound on said second surface and wherein said contacting is conducted for a time and at a temperature and pressure sufficient to allow said ozone and said silicon compound to form a silicon oxide.
Patent IL-115018-A0 (IL)
Title: Methods of inhibiting primary endometrial hyperplasia
IPC: C07D333/56
Filed: 1995-08-21
Abstract: A method of inhibiting primary endometrial hyperplasia comprising administering to a human in need thereof an effective amount of a compound having formula (I) wherein R<1> and R<3> are independently hydrogen, -CH3, (a) or (b), wherein Ar is optionally substituted phenyl; R<2> is selected from the group consisting of pyrrolidine, hexamethyleneimino, and piperidino; or a pharmaceutically acceptable salt or solvate thereof.
Patent IL-122315-A0 (IL)
Title: Cyclic peptide antifungal agents
IPC: C07K14/41
Filed: 1997-11-27
Abstract: Provided are compounds of the formula (1): <CHEM>  wherein R' is hydrogen, methyl or NH2C(O)CH2-;     R'' is methyl or hydrogen;     R is hydroxy or hydrogen;     R1 is hydroxy, hydrogen, or hydroxysulfonyloxy;     R7 is hydroxy, hydrogen, hydroxysulfonyloxy or phosphonooxy; R2 is a novel acyl side chain. Also provided are novel formulations, methods of inhibiting fungal and parasitic activity, and a process for preparing dideoxy (R=H) forms of the compounds.
Patent IL-137100-A0 (IL)
Title: Tts containing an antioxidant
IPC: A61K47/10
Filed: 1999-01-08
Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
Patent IL-139556-A0 (IL)
Title: Method for preventing replication in cryptosporidium parvum using ultraviolet light
IPC: C02F1/32
Filed: 1999-05-05
Abstract: A method for prevention of cryptosporidium oocysts and similar organisms in water by irradiating the water with ultraviolet light in a range of 200 to 300 nm in doses of about 10 mJ/cm2 to 175 mJ/cm2.
Patent IL-142860-A0 (IL)
Title: Signalling beacon
IPC: G08B5/36
Filed: 1999-09-02
Abstract: The signalling beacon is comprised of a lighting indicator which is mounted in a body (6) enabling the stacking thereof, energy accumulation device (7), at least one photovoltaic cell (3) and an electronic device (4) of the beacon (1), said electronic device (4) having a radio frequency receiver circuit to receive radiocommunication signals which are emitted by an emitter circuit, and a light indicator control circuit. The beacon is characterized in that the light indicator control circuit includes a timer, a logic circuit intended to the polarization of the timer and of the light indicator, and a connection device for the switching off of the energy accumulation device (7) when said beacons (1) are piled up. A signalling beacon is obtained with a high autonomy, which is also remote controllable and with a high versatility of applications. <IMAGE>
Patent IL-144964-A0 (IL)
Title: Methods of treatment of mitochondrial disorders
IPC: A61K31/7072
Filed: 2000-02-23
Abstract: In accordance with the present invention, there are provided methods for the treatment of mitochondrial disorders. Invention methods include the administration of a pyrimidine-based nucleoside such as triacetyluridine, or the like. Also provided are methods of reducing or eliminating symptoms associated with mitochondrial disorders. Mitochondrial disorders particularly appropriate for treatment include those attributable to a deficiency of one or more pyrimidines.
Patent IL-152074-A0 (IL)
Title: Pharmaceutical preparations and their manufacture
IPC: A61J3/06
Filed: 2001-04-05
Abstract: A method for making a composition comprising active particles comprising an active substance comprises the steps of a) providing an emulsion having a dispersed phase comprising a solution of the active substance in a solvent and b) inducing the formation, in the emulsion, of solid particles comprising the active substance. The particles may be isolated from the emulsion. Active particles having a normalized kurtosis of at least 5 and a mean diameter of less than 100 mum are provided.
Patent IL-152345-A0 (IL)
Title: Needleless syringe functioning with a double-composition pyrotechnic charge
IPC: C06B45/02
Filed: 2001-03-27
Abstract: The technical field of the invention is that of pre-filled and disposable needleless syringes, used for intradermal, subcutaneous and intramuscular injections of liquid active principle for therapeutic use in human and veterinary medicine. The inventive syringes ( 1 ) are mainly characterized in that they function with a pyrotechnic charge ( 6 ) consisting of a mixture of powder with high burning rate and a powder with low burning rate. Indeed, the combustion of the powder with a high burning rate enables to communicate instantly, through a piston ( 3 ), a very high speed to the active principle ( 4 ), whereas the combustion of the powder with a low burning rate enables to maintain a threshold pressure level to proceed with the injection, so as to ensure that the active principle ( 4 ) penetrates through the skin. Thus, the injection is properly and homogeneously without any loss of active liquid ( 4 ).
Patent IL-153818-A0 (IL)
Title: Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
IPC: C12Q/
Filed: 2001-07-05
Abstract: Identifying (M1) compounds (A) that modify, in an organism, the activity of at least one signal transduction pathway that depends on a G protein coupled receptor (GPCR). Cells that contain at least one GPCR-dependent pathway and at least one G protein are treated with test compounds and the qualitative and quantitative effect of the compound on the pathway is determined from a measurement signal that depends on the pathway. Independent claims are also included for the following: (1) (A) identified by (M1); (2) polynucleotides (I) that encode a polypeptide with G protein properties; (3) host cells containing (I) ; (4) method for producing cells containing (I); and (5) proteins (II) having sequences, reproduced, of 359 amino acids (aa) (S2), 353 aa (S4), 353 aa (S6) and 374 aa (S10).
Patent IL-178946-A0 (IL)
Title: Apparatus and methods for slurry cleaning of etch chambers
Filed: 2006-10-31
Abstract: Described are methods of cleaning debris from semiconductor etch chambers or chamber components, one method comprising directing atomized abrasive slurry onto at least some internal surfaces of such a chamber or chamber components. Apparatus for carrying out the methods are also described.
Patent IL-184826-A0 (IL)
Title: Accelerated uv curing
Filed: 2007-07-25
Abstract: The invention relates to the use of an infrared absorber for accelerating the UV curing of a mass to be cured. The infrared absorber is preferably selected from ATO, ITO, ZnO, LaB6 and a mixture of said substances. A casting resin is preferably used as the mass to be cured, in particular a resin based on an acrylic resin or an acrylate resin. The invention permits the production of laminated panes, in which the starting mass is applied between the panes and converted to form the laminate.
Patent IL-195187-A0 (IL)
Title: Process for production of radioactive fluorine-labeled organic compound
Filed: 2008-11-10
Abstract: Provided is a process for production of [ 18 F]FACBC, which can reduce the production amount of impurities. Disclosed is a process for production of a radioactive fluorine-labeled organic compound, which comprises: 
a deesterification step of retaining, in a reverse-phase column, a compound represented by Formula (1):   
wherein R 1  is a linear or branched C 1 -C 10  alkyl chain or an aromatic substituent; and R 2  is a protecting group; charging the column with an alkaline solution to deesterify the compound, and subsequently discharging the alkaline solution from the column to obtain a compound represented by Formula (2):   
wherein X is sodium or potassium; and 
a deprotection step of deprotecting the amino-protecting group of the compound obtained in the deesterification step to obtain a compound represented by Formula (3):
Patent IL-200059-A0 (IL)
Title: Electrodes with mechanically roughened surface for electrochemical applications
Filed: 2009-07-23
Abstract: The invention relates to a method for roughening the surface of a metal sheet used as electrode support in industrial electrochemical applications, and an electrode made by such method. Mechanical roughening is imparted by skin-passing the sheet between two rollers of a rolling mill, at least one of which is patterned according to a predetermined profile to be transferred by compression to the surface of the metal sheet.
Patent RO-132190-A0 (RO)
Title: Process of immunological treatment with biological products in epidermolysis bullosa, named pc2
Inventor: CHIURCIU CONSTANTIN
IPC: A61K39/395
Filed: 2017-06-13
Abstract: The invention relates to a process for preparing biological products which are used in the treatment of epidermolysis bullosa, with lesions infected with pathogenic agents. According to the invention, the process consists in preparing a mixture of inactivated bacterial and fungal antigens pathogenic for humans, for general treatment, and of bacterial strains sampled from bullous lesions of patients suffering from epidermolysis bullosa, for personalized treatment, the antigens being inoculated to chickens, conventional or specific-pathogen free ones (SPF), and after the immunization period, eggs are collected with a view to evaluating the immune response, to be processed by extraction technics for preparing immunoglobulins Y (IgY), as antibodies specific to the inoculated antigens, the immunologically-active fractions with anti-microbial, anti-inflammatory and immunomodulatory effects are isolated from the egg white, the resulting proteins are conditioned as whole-egg lyophilized powder, sterile drinkable solution, sprayable solution or solution for aerosols, for a topical administration and as IgY-containing ointment/cream for cutaneous administration.